James G. Robertson
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Peptidase Inhibition and Analysis, Biochemical and Molecular Research, Enzyme Structure and Function, Neuropeptides and Animal Physiology
Most-Cited Works
- → Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes(2005)619 cited
- → Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes(2008)617 cited
- → Mechanistic Basis of Enzyme-Targeted Drugs(2005)247 cited
- → Localizing the NADP+ binding site on the MurB enzyme by NMR(1996)228 cited
- → 4-Thiazolidinones: novel inhibitors of the bacterial enzyme murB(2000)218 cited
- → Synthesis of Novel Potent Dipeptidyl Peptidase IV Inhibitors with Enhanced Chemical Stability: Interplay between the N-Terminal Amino Acid Alkyl Side Chain and the Cyclopropyl Group of α-Aminoacyl-l-cis-4,5-methanoprolinenitrile-Based Inhibitors(2004)103 cited
- → Enzymes as a special class of therapeutic target: clinical drugs and modes of action(2007)72 cited
- → Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2(2008)57 cited
- → Characterization of NADP+ binding to perdeuterated MurB: backbone atom NMR assignments and chemical-shift changes(1997)52 cited
- → Mitogenic whey extract stimulates wound repair activity in vitro and promotes healing of rat incisional wounds(2000)41 cited